Biomarkers as prognostic factors in endometrial cancer.
Endometrial cancer is the most common gynecologic malignancy in more developed countries. Approximately 75% of cases are diagnosed at an early stage with a tumor confined to the uterine corpus. Although most patients are cured by surgery alone, about 15-20% with no signs of locally advanced or metas...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Via Medica
2010-11-01
|
| Series: | Folia Histochemica et Cytobiologica |
| Online Access: | http://czasopisma.viamedica.pl/fhc/article/view/4195 |